Betaseron 0.3 MG kits
Ended Awarded
- Contract number
- SPE2DB25FAWJM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,781
Award facts
- Contract value 100% obligated
- $11,780.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Betaseron 0.3 mg kits. This firm fixed-price delivery order, valued at $11,780.82, was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025. The contract carries no set-aside designation and will be performed in Conshohocken, Pennsylvania. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at approximately $500 million through November 2026, which enables the agency to procure an extensive range of pharmaceutical products and medical consumables to support Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group, headquartered in Park Ridge, Illinois, and registered in SAM.gov since 2001, serves as a critical pharmaceutical supplier in the federal supply chain. The company specializes in distributing branded and generic prescription drugs, biologics, over-the-counter medications, and specialized medical products to military and federal healthcare systems. Betaseron, an interferon beta-1b product used to treat multiple sclerosis, represents part of the company's comprehensive portfolio of injectable pharmaceuticals and specialty medications routinely supplied to Department of Defense medical facilities through the DLA procurement vehicle.
Quick answers
Who was awarded contract SPE2DB25FAWJM?
SPE2DB25FAWJM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FAWJM worth?
The government has obligated $11,781 on SPE2DB25FAWJM.
Is contract SPE2DB25FAWJM an order under another contract?
Yes. SPE2DB25FAWJM is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAWJM competed?
The extent of competition for SPE2DB25FAWJM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award